BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Morais V, Texeira E, Suarez N. Next-Generation Whole-Cell Pneumococcal Vaccine. Vaccines (Basel) 2019;7:E151. [PMID: 31623286 DOI: 10.3390/vaccines7040151] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Masomian M, Ahmad Z, Gew LT, Poh CL. Development of Next Generation Streptococcus pneumoniae Vaccines Conferring Broad Protection. Vaccines (Basel) 2020;8:E132. [PMID: 32192117 DOI: 10.3390/vaccines8010132] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 11.0] [Reference Citation Analysis]
2 Singh R, Capalash N, Sharma P. Vaccine development to control the rising scourge of antibiotic-resistant Acinetobacter baumannii: a systematic review. 3 Biotech 2022;12:85. [PMID: 35261870 DOI: 10.1007/s13205-022-03148-9] [Reference Citation Analysis]
3 Malchrzak W, Mastalerz-Migas A. Epidemiologic Benefits of Pneumococcal Vaccine Introduction into Preventive Vaccination Programs. Adv Exp Med Biol 2021;1324:11-9. [PMID: 33136238 DOI: 10.1007/5584_2020_589] [Reference Citation Analysis]
4 Oliveira GS, Oliveira MLS, Miyaji EN, Rodrigues TC. Pneumococcal Vaccines: Past Findings, Present Work, and Future Strategies. Vaccines (Basel) 2021;9:1338. [PMID: 34835269 DOI: 10.3390/vaccines9111338] [Reference Citation Analysis]
5 Thaulow CM, Lindemann PC, Klingenberg C, Berild D, Salvesen Blix H, Myklebust TÅ, Harthug S. Epidemiology and Antimicrobial Susceptibility of Invasive Bacterial Infections in Children-A Population-Based Study From Norway. Pediatr Infect Dis J 2021;40:403-10. [PMID: 33298760 DOI: 10.1097/INF.0000000000003013] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]